Development of Balanced Whole System Value Measures for Inflammatory Bowel Disease Care in the IBD Qorus Collaborative Using a Modified Delphi Process.

inflammatory bowel disease modified delphi process patient-reported experience measures patient-reported outcome measures patient-reported outcomes quality improvement value compass value measures

Journal

Inflammatory bowel diseases
ISSN: 1536-4844
Titre abrégé: Inflamm Bowel Dis
Pays: England
ID NLM: 9508162

Informations de publication

Date de publication:
02 03 2022
Historique:
received: 05 11 2020
pubmed: 27 5 2021
medline: 1 4 2022
entrez: 26 5 2021
Statut: ppublish

Résumé

The IBD Qorus Collaborative aims to reduce variation and increase the value of care for the adult inflammatory bowel disease (IBD) community. To evaluate the success of the collaborative, we aimed to develop a balanced set of outcome measures that reflect a multistakeholder view of value in IBD care. To achieve this, we used the Clinical Value Compass framework and engaged a mixed-stakeholder group to conduct a modified Delphi process. The end result was a 10-measure set to assess the value of IBD care. The modified Delphi process included 3 iterative rounds of blinded voting and interactive webinar-style discussion. We recruited 18 participants for the Delphi panel, including clinicians, researchers, patients, Crohn's & Colitis Foundation staff, and payers. Participants first identified constructs to measure, then identified the tools to measure those constructs. A literature review and environmental scan of current measures in 4 domains were performed, and relevant measures were proposed for discussion and voting in each domain. Throughout the process, participants were invited to contribute additional measures. The modified Delphi process led to selection of 10 value measures across 4 domains: (1) patient experience; (2) functional status; (3) clinical status; and (4) health care costs and utilization. We have successfully completed a 3-stage modified Delphi process to develop a balanced set of value measures for adult IBD care. The value measure set expands upon prior efforts that have established quality measures for IBD care by adding cost and experience of care elements. This work positions IBD Qorus to better assess, study, improve, and demonstrate value at individual, system, and population levels and will inform and empower related research, improvement, and implementation efforts.

Sections du résumé

BACKGROUND
The IBD Qorus Collaborative aims to reduce variation and increase the value of care for the adult inflammatory bowel disease (IBD) community. To evaluate the success of the collaborative, we aimed to develop a balanced set of outcome measures that reflect a multistakeholder view of value in IBD care. To achieve this, we used the Clinical Value Compass framework and engaged a mixed-stakeholder group to conduct a modified Delphi process. The end result was a 10-measure set to assess the value of IBD care.
METHOD
The modified Delphi process included 3 iterative rounds of blinded voting and interactive webinar-style discussion. We recruited 18 participants for the Delphi panel, including clinicians, researchers, patients, Crohn's & Colitis Foundation staff, and payers. Participants first identified constructs to measure, then identified the tools to measure those constructs. A literature review and environmental scan of current measures in 4 domains were performed, and relevant measures were proposed for discussion and voting in each domain. Throughout the process, participants were invited to contribute additional measures.
CONCLUSION
The modified Delphi process led to selection of 10 value measures across 4 domains: (1) patient experience; (2) functional status; (3) clinical status; and (4) health care costs and utilization. We have successfully completed a 3-stage modified Delphi process to develop a balanced set of value measures for adult IBD care. The value measure set expands upon prior efforts that have established quality measures for IBD care by adding cost and experience of care elements. This work positions IBD Qorus to better assess, study, improve, and demonstrate value at individual, system, and population levels and will inform and empower related research, improvement, and implementation efforts.

Identifiants

pubmed: 34037211
pii: 6284056
doi: 10.1093/ibd/izab091
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

327-336

Informations de copyright

© 2021 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Brant J Oliver (BJ)

Departments of Community & Family Medicine, Psychiatry, and the Dartmouth Institute, Geisel School of Medicine at Dartmouth, USA.

Alice M Kennedy (AM)

The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine and Dartmouth, Lebanon, New Hampshire, USA.

Welmoed K van Deen (WK)

Cedars-Sinai Medical Center, Los Angeles, California, USA.

S Alandra Weaver (SA)

The Crohn's & Colitis Foundation, New York, New York, USA.

Caren Heller (C)

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.

Megan M Holthoff (MM)

The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine and Dartmouth, Lebanon, New Hampshire, USA.

Jeffrey Bank (J)

University of Utah Health, Salt Lake City, Utah, USA.

Gil Y Melmed (GY)

The Crohn's & Colitis Foundation, New York, New York, USA.

Corey A Siegel (CA)

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.

Eugene C Nelson (EC)

The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine and Dartmouth, Lebanon, New Hampshire, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH